Botulism Illness Treatment Market Size, Share, Growth Insights, Key Developments, Industry Analysis and Forecast to 2023

Botulism Illness Treatment Market Size, Share, Growth Insights, Key Developments, Industry Analysis and Forecast to 2023

Botulism illness is a rare diseases caused by a toxin from bacteria Clostridium botulinum. This toxin causes paralysis and can be worse if not been treated at early stages. This bacteria can be enter into the body by food, water or environment. Home-canned foods are the most common source for foodborne botulism. Patients suffering from this diseases may experience double or blurred vision, droopy eyelids, difficulty speaking and a dry mouth. In severe cases, patient have trouble swallowing and breathing.

The global botulism illness market is driven by increasing prevalence of diseases, availability of the effective treatment and increasing awareness among people. Continuous development in the healthcare sector has also contributed in the growth of the market. On other hand high cost of research has hampered the growth of the market.

Botulism Illness Treatment Market Size is expected to grow at a CAGR of 5.9% during forecasted period 2017-2023
Segmentation:

Global botulism illness market is segmented on the basis of type, into botulinum type A and botulinum type B. On the basis of drug type, the market is segmented into antibiotics, antitoxins and others. Antitoxin are further sub segmented into trivalent antitoxin and heptavalent botulinium antitoxin and on the basis end users, the market is segmented into hospital, clinics and other. 

Regional Analysis

Geographically, Global botulism illness market is dominated by America which is followed by Europe. Asia Pacific has the fastest growing market for botulism illness. Presence of number of developing economies and lack of awareness of hygiene among the people has driven the market growth in Asia Pacific region. India and China are the major contributors for the market. Presence of huge population pool and rapidly developing healthcare sector with increasing healthcare expenditure has boosted the growth of this market in India and China.

Competitive Analysis

The key players for the global botulism illness market are Allergan Inc. (Ireland), XOMA Corporation (US), Pfizer Inc. (US), AlphaVax, Inc (US), Microbiotix, Inc (US), Molecular Targeting Technologies, Inc (US), Ipsen Technologies Pvt. Ltd (France), Galderma S. A. (Switzerland), Canbex Therapeutics Ltd (US), Azidus (US)

Global botulism illness market is a dominated by major players. Though there are many small companies preset in the market but the huge share is acquired by major companies. Major players are trying to focus on acquisition and strategic alliances with local companies to minimize the competition.

Pfizer Inc. is an American pharmaceutical company headquartered in New York. It is one of the world's largest pharmaceutical companies that develops and produces medicines and vaccines for a wide range of medical disciplines. Ultravac and Longrange are botulinum vaccine widely used in the treatment of the botulism.

Regional Analysis

Geographically, Global botulism illness market is dominated by America which is followed by Europe. Asia Pacific has the fastest growing market for botulism illness. Presence of number of developing economies and lack of awareness of hygiene among the people has driven the market growth in Asia Pacific region. India and China are the major contributors for the market. Presence of huge population pool and rapidly developing healthcare sector with increasing healthcare expenditure has boosted the growth of this market in India and China.

Regional Analysis

Geographically, Global botulism illness market is dominated by America which is followed by Europe. Asia Pacific has the fastest growing market for botulism illness. Presence of number of developing economies and lack of awareness of hygiene among the people has driven the market growth in Asia Pacific region. India and China are the major contributors for the market. Presence of huge population pool and rapidly developing healthcare sector with increasing healthcare expenditure has boosted the growth of this market in India and China.

 

Related Posts

Log in to post a comment.